Zoe Hughes-Thomas

Title: Zoe Hughes-Thomas: Innovator in Antigen Binding Constructs

Introduction

Zoe Hughes-Thomas is a prominent inventor based in Stevenage, GB. She has made significant contributions to the field of biotechnology, particularly in the development of antigen binding constructs. Her work focuses on innovative solutions for treating diseases associated with vascular endothelial growth factor (VEGF) signaling.

Latest Patents

Zoe holds a patent for her invention titled "Antigen binding constructs." This invention comprises one or two epitope binding domains separated by a single chain Fc region of an antibody. Each epitope binding domain is capable of binding to VEGF. The patent also includes dimers comprising two antigen binding constructs, pharmaceutical compositions containing these dimers, and their applications in treating conditions such as diabetic macular edema (DME), wet age-related macular degeneration (Wet AMD), diabetic retinopathy, retinal vein occlusion (RVO), and corneal neovascularization. Additionally, it covers polynucleotide sequences encoding the antigen binding constructs. Zoe has 1 patent to her name.

Career Highlights

Zoe is currently employed at Glaxo Group Limited, where she continues to advance her research and development efforts. Her work has the potential to significantly impact the treatment of various eye diseases and other conditions related to VEGF signaling.

Collaborations

Zoe collaborates with talented professionals in her field, including Claire Ashman and Ian Richard Catchpole. These partnerships enhance her research and contribute to the innovative solutions being developed at Glaxo Group Limited.

Conclusion

Zoe Hughes-Thomas is a dedicated inventor whose work in antigen binding constructs is paving the way for new treatments in biotechnology. Her contributions are vital to addressing significant health challenges associated with VEGF signaling.